← FDA ENFORCEMENT
D-0074-2024Class II

GlaxoSmithKline Consumer Healthcare Holdings LLC

Recalling firm
GlaxoSmithKline Consumer Healthcare Holdings LLC
Product type
Drug
Status
Completed
Report date
2023-11-08
Distribution
Nationwide within the United States
Firm state
MO
Product quantity
N/A
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Product description

TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-01, UPC 3-0766-0746-80-5

Code / lot info

Lot #: HA7G, Exp. Date 8/31/2027

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.